Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity (Q28217965)

Annals of Pharmacotherapy

Europe PubMed Central

title

Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity (English)

0 references

1 reference

Aaron M Drucker

2

0 references

author name string

Sandra R Knowles

series ordinal

1

0 references

Elizabeth A Weber

series ordinal

3

0 references

Neil H Shear

series ordinal

4

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

41

0 references

issue

7

0 references

page(s)

1191-200

0 references

cites work

Aspirin and NSAID sensitivity

1 reference

Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review

21 January 2018

1 reference

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

21 January 2018

1 reference

Aspirin sensitivity: implications for patients with coronary artery disease

21 January 2018

1 reference

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management

21 January 2018

1 reference

21 January 2018

Aspirin-sensitive asthma

1 reference

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

21 January 2018

1 reference

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

21 January 2018

1 reference

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study

21 January 2018

1 reference

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

21 January 2018

1 reference

Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan

21 January 2018

1 reference

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

21 January 2018

1 reference

21 January 2018

1 reference

Aspirin-induced asthma: clinical aspects, pathogenesis and management

21 January 2018

1 reference

Can NSAIDs intolerance disappear? A study of three cases

21 January 2018

1 reference

Best evidence topic report. Non-steroidal anti-inflammatory drugs and exacerbations of asthma in children.

21 January 2018

1 reference

Aspirin sensitivity and urticaria

21 January 2018

1 reference

Mechanism of chronic urticaria exacerbation by aspirin

21 January 2018

1 reference

The broken balance in aspirin hypersensitivity

21 January 2018

1 reference

Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria

21 January 2018

1 reference

Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma

21 January 2018

1 reference

Genetic mechanism of aspirin-induced urticaria/angioedema

21 January 2018

1 reference

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

21 January 2018

1 reference

Aspirin induced adverse skin reactions: new pathophysiological aspects

21 January 2018

1 reference

Testing for aspirin hypersensitivity

21 January 2018

1 reference

A new insight into aspirin-induced asthma

21 January 2018

1 reference

Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma

21 January 2018

1 reference

Clinical features and diagnosis of aspirin induced asthma

21 January 2018

1 reference

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

21 January 2018

1 reference

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period

21 January 2018

1 reference

Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Individual monitoring of aspirin desensitization

21 January 2018

1 reference

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper

21 January 2018

1 reference

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug-induced reactions and desensitization

21 January 2018

1 reference

Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting

21 January 2018

1 reference

Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy

21 January 2018

1 reference

Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics

21 January 2018

1 reference

Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics

21 January 2018

1 reference

Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma

21 January 2018

1 reference

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo

21 January 2018

1 reference

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

21 January 2018

1 reference

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema

21 January 2018

1 reference

Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria

21 January 2018

1 reference

Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues

21 January 2018

1 reference

Tacrolimus reduces urinary excretion of leukotriene E(4) and inhibits aspirin-induced asthma to threshold dose of aspirin

21 January 2018

1 reference

Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes

21 January 2018

1 reference

Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib

21 January 2018

1 reference

Safety of COX-2 Inhibitors in Asthma Patients with Aspirin Hypersensitivity

21 January 2018

1 reference

Safety of a specific COX-2 inhibitor in aspirin-induced asthma

21 January 2018

1 reference

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

21 January 2018

1 reference

The safety of celecoxib in patients with aspirin-sensitive asthma

21 January 2018

1 reference

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

21 January 2018

1 reference

Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review.

21 January 2018

1 reference

Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance

21 January 2018

1 reference

Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib

21 January 2018

1 reference

Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen

21 January 2018

1 reference

Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma

21 January 2018

1 reference

Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)

21 January 2018

1 reference

Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema

21 January 2018

1 reference

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib

21 January 2018

1 reference

Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties

21 January 2018

1 reference

Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects.

21 January 2018

1 reference

Salsalate cross-sensitivity in aspirin-sensitive patients with asthma.

21 January 2018

1 reference

Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance

21 January 2018

1 reference